Syphilinum homeopathic drug recalled for manufacturing practice deviations
Washington Homeopathic Products is recalling Syphilinum homeopathic products in multiple potencies due to current good manufacturing practice deviations. The affected products were distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily by the manufacturer due to current good manufacturing practice deviations, with no reported illnesses or injuries. The recall is precautionary in nature, consistent with a Moderate severity classification.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Syphilinum homeopathic product in multiple potencies (9C, 30C, 200C, 10X, and 12X) supplied as liquid pellets. The affected lot numbers are 20390, 20441, and 20389.
The recall was initiated due to current good manufacturing practice (cGMP) deviations. Washington Homeopathic Products voluntarily initiated the recall on May 13, 2022. The products were distributed nationwide throughout the United States.
Consumers who have purchased this product should contact Washington Homeopathic Products, Inc. in Berkeley Springs, West Virginia, or consult with their healthcare provider for guidance on this recall.
The recalled product
- Product
- Syphilinum, Potency: 9C, 30C, 200C, 10X, 12X, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 20390
- 20441
- 20389
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 17 recalled by Washington Homeopathic Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Washington Homeopathic Products, Inc.
See all →- LowHomeopathic Kit Recalled for Label Mix-up Between Products
FDA (Drugs) · 2024-07-31
- ModerateHomeopathic Drug Recall: Vaccinotoxinum Products Due to Manufacturing Violations
FDA (Drugs) · 2022-06-22
- ModerateDrug recall: Tuberculinum Bovinum due to manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModeratePyrogenium Homeopathic Remedy Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Colibacillinum Drug Recall Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- HighWashington Homeopathic Products Recalls Silicea 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Natrum Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Natrum Muriaticum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Products Recalls Kali Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Ferrum Phosphoricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Products Recalls Kali Muriaticum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27